Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Maike Oey, Andrea Stroux, Philipp Hemmati, Jörg Westermann, Olga Blau, Friedrich Wittenbecher, Kamran Movassaghi, Martin Szyska, Sybill Thomas, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2014) 124 (6): 963–972.

https://doi.org/10.1182/blood-2013-11-539031

Published: 2014

Includes: Supplemental data

Journal Articles

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Christoph Ochs, Philipp Hemmati, MD, Giang Lam Vuong, MD, Kathrin Rieger, Olga Blau, Jörg Westermann, MD, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2013) 122 (21): 4605.

https://doi.org/10.1182/blood.V122.21.4605.4605

Published: 2013

Journal Articles

Human CD1c + dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja Steinfelder, Federica Facciotti, Paola Gruarin, Annalisa Bianco, Bodo Steckel, Monica Moro, Mariacristina Crosti, Chiara Romagnani, Katharina Stölzel, Sara Torretta, Lorenzo Pignataro, Carmen Scheibenbogen, Petra Neddermann, Raffaele De Francesco, Sergio Abrignani, Jens Geginat

Blood (2013) 122 (6): 932–942.

https://doi.org/10.1182/blood-2013-04-495424

Published: 2013

Includes: Supplemental data

Journal Articles

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

Ulrich Keilholz, Anne Letsch, Antonia Busse, Anne Marie Asemissen, Sandra Bauer, Igor Wolfgang Blau, Wolf-Karsten Hofmann, Lutz Uharek, Eckhard Thiel, Carmen Scheibenbogen

Blood (2009) 113 (26): 6541–6548.

https://doi.org/10.1182/blood-2009-02-202598

Published: 2009

Journal Articles

Histone Deacetylase Inhibition Improves Differentiation of Dendritic Cells from Leukemic Blasts of Patients with TEL/AML1-Positive Acute Lymphoblastic Leukemia

Kerstin Schmidt, MSc, Karl Seeger, MD, PhD, Carmen Scheibenbogen, Roderich Bender, MD, Sina Süßmilch, Abdulgabar Salama, Anja Moldenhauer, MD

Blood (2008) 112 (11): 3952.

https://doi.org/10.1182/blood.V112.11.3952.3952

Published: 2008

Journal Articles

Analysis of Immunological and Clinical Response Kinetics to WT1 Peptide Vaccine in Patients with AML and MDS: Need for Supplementation of IWG Response Criteria?.

Ulrich Keilholz, MD, Anne Letsch, MD, Antonia Busse, MD, Annemarie Asemissen, MD, Igor W. Blau, MD, Wolf K. Hofmann, MD, Lutz Uharek, MD, Eckhard Thiel, MD, Carmen Scheibenbogen, MD

Blood (2007) 110 (11): 902.

https://doi.org/10.1182/blood.V110.11.902.902

Published: 2007

Journal Articles

Human Bone Marrow as a Source of Multifunctional CMV-Specific CD4+ T Cells for Adoptive Cell Therapy.

Il-Kang Na, MD, Anne Letsch, M.D., Ines Noack, Sandra Bauer, Jens Geginat, Petra Reinke, M.D., Hans Dieter Volk, M.D., Eckhard Thiel, M.D., Carmen Scheibenbogen, M.D.

Blood (2007) 110 (11): 2973.

https://doi.org/10.1182/blood.V110.11.2973.2973

Published: 2007

Journal Articles

Clinical and Immunological Activity of WT1 Peptide Vaccination in Patients with Acute Myeloid Leukemia and Myelodysplasia: Results of a Phase II Trial.

Ulrich Keilholz, MD, Anne Letsch, Antonia Busse, Anne M. Asemissen, Alexander Schmittel, Wolf K. Hofmann, Lutz Uharek, Igor W. Blau, Eckhard Thiel, Carmen Scheibenbogen

Blood (2006) 108 (11): 567.

https://doi.org/10.1182/blood.V108.11.567.567

Published: 2006

Journal Articles

Vaccination with the WT-1 126-134 Peptide in Patients with Acute Myeloid Leukemia after Allogenic Stem Cell Transplantation.

Chiara Gentilini, MD, Anne Letsch, MD, Annemarie Asemissen, MD, Arne Muessig, MD, Katrin Rieger, MD, Carmen Scheibenbogen, Eckhard Thiel, Lutz Uharek

Blood (2006) 108 (11): 3683.

https://doi.org/10.1182/blood.V108.11.3683.3683

Published: 2006

Journal Articles

Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2

Robert Godal, Ulrich Keilholz, Lutz Uharek, Anne Letsch, Anne Marie Asemissen, Antonia Busse, Il-Kang Na, Eckhard Thiel, Carmen Scheibenbogen

Blood (2006) 107 (8): 3205–3211.

https://doi.org/10.1182/blood-2005-07-2880

Published: 2006

Journal Articles

Quantification and Characterization of Peripheral Blood Natural Killer (NK) Cells Mediating Rituximab and Alemtuzumab Dependent Cytotoxicity.

Olaf Penack, MD, Lars Fischer, MD, Chiara Gentilini, MD, Anne M. Asemissen, MD, Carmen Scheibenbogen, MD, Eckhard Thiel, MD, Lutz Uharek, MD

Blood (2005) 106 (11): 2808.

https://doi.org/10.1182/blood.V106.11.2808.2808

Published: 2005

Journal Articles

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Chiara Gentilini, MD, Urte Hilbers, Susanne Ganepola, MD, Carmen Scheibenbogen, Katy Freyberg, Dietger W. Niederwieser, Eckhard Thiel, Lutz Uharek

Blood (2005) 106 (11): 598.

https://doi.org/10.1182/blood.V106.11.598.598

Published: 2005

Journal Articles

WT1-Peptide Vaccination Shows High Immunogenicity and Clinical Activity in Patients with Acute Myeloid Leukemia.

Keilholz Ulrich, MD, Carmen Scheibenbogen, MD, Anne Letsch, MD, Anne Marie Asemissen, MD, Wolf Karsten Hofmann, MD, Lutz Uharek, MD, Blau Wolfgang, MD, Thiel Eckhard, MD

Blood (2005) 106 (11): 406.

https://doi.org/10.1182/blood.V106.11.406.406

Published: 2005

Journal Articles

Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma

Kristoph Jahnke, Sarah E. Coupland, Il-Kang Na, Christoph Loddenkemper, Ulrich Keilholz, Agnieszka Korfel, Harald Stein, Eckhard Thiel, Carmen Scheibenbogen

Blood (2005) 106 (1): 384–385.

https://doi.org/10.1182/blood-2005-01-0324

Published: 2005

Journal Articles

A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3 + LGL-leukemia

Danila Valmori, Maha Ayyoub, Charles S. Hesdorffer, Ulrich Keilholz, Carmen Scheibenbogen

Blood (2003) 101 (11): 4643–4644.

https://doi.org/10.1182/blood-2003-03-0828

Published: 2003

Journal Articles

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

Carmen Scheibenbogen, Anne Letsch, Eckhard Thiel, Alexander Schmittel, Volker Mailaender, Steffi Baerwolf, Dirk Nagorsen, Ulrich Keilholz

Blood (2002) 100 (6): 2132–2137.

https://doi.org/10.1182/blood-2002-01-0163

Published: 2002

NARROW

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Human CD1c + dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

Histone Deacetylase Inhibition Improves Differentiation of Dendritic Cells from Leukemic Blasts of Patients with TEL/AML1-Positive Acute Lymphoblastic Leukemia

Analysis of Immunological and Clinical Response Kinetics to WT1 Peptide Vaccine in Patients with AML and MDS: Need for Supplementation of IWG Response Criteria?.

Human Bone Marrow as a Source of Multifunctional CMV-Specific CD4+ T Cells for Adoptive Cell Therapy.

Clinical and Immunological Activity of WT1 Peptide Vaccination in Patients with Acute Myeloid Leukemia and Myelodysplasia: Results of a Phase II Trial.

Vaccination with the WT-1 126-134 Peptide in Patients with Acute Myeloid Leukemia after Allogenic Stem Cell Transplantation.

Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2

Quantification and Characterization of Peripheral Blood Natural Killer (NK) Cells Mediating Rituximab and Alemtuzumab Dependent Cytotoxicity.

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

WT1-Peptide Vaccination Shows High Immunogenicity and Clinical Activity in Patients with Acute Myeloid Leukemia.

Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma

A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3 + LGL-leukemia

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only